Children’s Hospital Los Angeles hosts the CTIP Accelerator Symposium, which promotes patient participation in the development of pediatric medical devices


July 22, 2022

LOS ANGELES–(BUSINESS WIRE)–The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP), based at Children’s Hospital Los Angeles (CHLA), presented its 2022 symposium entitled Patient Impact, Patient Voice, which brought together innovators, clinicians and patient families came together virtually to discuss the importance of better involving patients and their perspectives in the design, development and research of pediatric medical devices. The symposium featured panelists consisting of patient families and advocates, CTIP-funded developers of pediatric medical devices, executives from the Food and Drug Administration’s (FDA) Office of Strategic Partnerships and Technology Innovation, and representatives from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Capital Consortium for Pediatric Device Innovation (NCC-PDI).

“In the world of pediatric medical devices, there are a number of systemic challenges when it comes to innovation and the ability to bring more devices to market to treat children. Although people under the age of 18 make up almost a quarter of the US population, less than 12 percent of the National Institutes of Health’s budget funds pediatric research and less than 10 percent of all health care spending goes to pediatrics,” says Juan Espinoza. MD, FAAP, Director and Principal Investigator of CTIP. “CTIP is committed to improving children’s health outcomes through the development of medical technology and is proud to support companies that actively engage patients to meet their needs through integratively designed medical devices.”

The following members of the CTIP portfolio attended the symposium:

Restoring independence for people with upper arm weakness – Abilitech Medical develops assistive technologies to meet the needs of patients with limited upper extremity mobility and provides shoulder and elbow support and support for patients with conditions such as muscular dystrophy.

Robotics for rehabilitation – BiomotumThe SPARK robotic ankle assist device improves the mobility and gait quality of patients with cerebral palsy, stroke and other neurological diseases through robotic gait training.

The solution for eyelid closure Nictawi‘s Tarsus Eyelid Patch is a patented eyelid closure device that harnesses the strengths of adhesion, structure, curvature and resilience to transform corneal care.

Spinal cord and brain retraining SpineX develops non-invasive neuromodulation devices that send low-intensity electrical pulses down the spine, restoring communication between the spine and the brain to enable voluntary movement in patients with conditions such as cerebral palsy.

The symposium also included pediatric patients and families who spoke about their daily lives, how they are affected by the medical devices they use, and how to better incorporate their perspectives in developing user-friendly devices for this population. They shared their unique stories about insights into life-changing technologies, but also the limitations and lack of opportunities for manufacturers to communicate and provide feedback. The symposium ended with remarks from representatives from the FDA, NIH, and NCC-PDI, who emphasized the need to connect patients and families with manufacturers, researchers, clinicians, educators, and other key stakeholders to ensure safe and effective medical devices are designed specifically for children .

About CTIP

The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) is a pediatric medical device accelerator based at Children’s Hospital Los Angeles (CHLA) in partnership with the University of Southern California. Founded in 2011 and first funded by the U.S. Food and Drug Administration (FDA) in 2013 and again in 2018, CTIP advances the commercialization and clinical deployment of pediatric medical device technologies. CTIP addresses the key component missing from pediatric device innovation: the simultaneous involvement of clinicians, engineers, regulators, hospital administrators, patients and the business community in the process of technology assessment and development. For portfolio companies, CTIP promotes networking opportunities, direct and indirect financial support, and guidance on issues related to, but not limited to, intellectual property, prototyping, engineering, testing, grant writing, and clinical trial design. CTIP has a network of children’s hospitals, academic institutions, accelerators and incubators throughout the West Coast to support the commercialization of pediatric medical devices. To learn more about CTIP, follow them on Facebook, Instagram, and LinkedIn Twitterand visit their website at

About Los Angeles Children’s Hospital

Children’s Hospital Los Angeles is a leader in pediatric medicine, providing recognized care to children from around the world, the country and the greater Southern California area. Founded in 1901, Children’s Hospital Los Angeles is the largest provider of child care in Los Angeles County, the No. 1 children’s hospital in the Pacific Region and California, and ranked among the top 10 in the country in US News & World Report’s Honors List of Best Children’s Hospitals. Clinical expertise spans the pediatric continuum of care from newborn to young adult, from everyday preventative medicine to the most advanced cases. Inclusive, child- and family-friendly clinical care is led by physicians who are faculty members of USC’s Keck School of Medicine, and proven discoveries reach patients faster through the Saban Research Institute of Children’s Hospital Los Angeles – a top 10 children’s hospital for the Funding from the National Institutes of Health. The hospital also hosts the largest pediatric continuing education program in a freestanding children’s hospital in the western United States. To learn more, follow us on Facebook, Instagram, LinkedIn, YouTube and Twitter and visit our blog at

Lauren song
Email: [email protected]


About Author

Comments are closed.